NCT00213772

Brief Summary

Comparison of patients with documented PCT and HCV infection, documented PCT without HCV, HCV infection without PCT and controls without HCV or PCT. Single blood + urine sample uptake to investigate : mutations in HFE gene, uroporphyrinogen decarboxylase activity, HCV genotye, history of disease.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
280

participants targeted

Target at P75+ for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 1999

Completed
6.4 years until next milestone

First Submitted

Initial submission to the registry

September 13, 2005

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 21, 2005

Completed
Last Updated

September 21, 2005

Status Verified

September 1, 2005

First QC Date

September 13, 2005

Last Update Submit

September 13, 2005

Conditions

Porphyria Cutanea Tarda

Keywords

Porphyria cutanea tardahepatitis Chemochromatosis

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Porphyria cutanea tarda /HCV negative Porphyria cutanea tarda/ HCV positive HCV positive HCV negative controls

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Porphyria Cutanea TardaHepatitis CHemochromatosis

Condition Hierarchy (Ancestors)

Porphyrias, HepaticLiver DiseasesDigestive System DiseasesSkin Diseases, GeneticGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesSkin DiseasesSkin and Connective Tissue DiseasesPorphyriasMetabolic DiseasesNutritional and Metabolic DiseasesBlood-Borne InfectionsCommunicable DiseasesInfectionsHepatitis, Viral, HumanVirus DiseasesFlaviviridae InfectionsRNA Virus InfectionsHepatitisMetal Metabolism, Inborn ErrorsMetabolism, Inborn ErrorsIron OverloadIron Metabolism Disorders

Study Officials

  • Bernard Cribier, MD

    Hopitaux Universitaires de Strasbourg

    PRINCIPAL INVESTIGATOR

  • O. Chosidow, MD

    Hopital Pitié-Salpétrière / Paris

    PRINCIPAL INVESTIGATOR

  • M. Bagot, MD

    Hopital Henri Mondor / CHU Créteil

    PRINCIPAL INVESTIGATOR

  • J.P Lacour, MD

    Hopital de l'Archet / CHU Nice

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

September 13, 2005

First Posted

September 21, 2005

Study Start

May 1, 1999

Last Updated

September 21, 2005

Record last verified: 2005-09